{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:19:43Z","timestamp":1791976783280,"version":"4.4.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006254","name":"Ruhr-Universit\u00e4t Bochum","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006254","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Type 2 diabetes mellitus (T2DM) represents a significant risk factor for cardiovascular disease, particularly heart failure with preserved ejection fraction (HFpEF). HFpEF predominantly affects elderly individuals and women, and is characterized by dysfunctions associated with metabolic, inflammatory, and oxidative stress pathways. Despite HFpEF being the most prevalent heart failure phenotype in patients with T2DM, its underlying pathophysiological mechanisms remain inadequately elucidated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>This study aims to investigate the effects of diabetes mellitus on myocardial inflammation, oxidative stress, and protein quality control (PQC) mechanisms in HFpEF, with particular emphasis on insulin signaling, autophagy, and chaperone-mediated stress responses.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We conducted an analysis of left ventricular myocardial tissue from HFpEF patients, both with and without diabetes, employing a range of molecular, biochemical, and functional assays. The passive stiffness of cardiomyocytes (Fpassive) was assessed in demembranated cardiomyocytes before and after implementing treatments aimed at reducing inflammation (IL-6 inhibition), oxidative stress (Mito-TEMPO), and enhancing PQC (HSP27, HSP70). Inflammatory markers (NF-\u03baB, IL-6, TNF-\u03b1, ICAM-1, VCAM-1, NLRP3), oxidative stress markers (ROS, GSH\/GSSG ratio, lipid peroxidation), and components of signaling pathways (PI3K\/AKT\/mTOR, AMPK, MAPK, and PKG) were evaluated using western blotting, immunofluorescence, and ELISA techniques.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Hearts from diabetic HFpEF patients exhibited significantly heightened inflammation, characterized by the upregulation of NF-\u03baB, IL-6, and the NLRP3 inflammasome. This increase in inflammation was accompanied by elevated oxidative stress, diminished nitric oxide (NO) bioavailability, and impaired activation of the NO-sGC-cGMP-PKG signaling pathway. Notably, dysregulation of insulin signaling was observed, as indicated by decreased AKT phosphorylation and impaired autophagy regulation mediated by AMPK and mTOR. Additionally, PQC dysfunction was evidenced by reduced expression levels of HSP27 and HSP70, which correlated with increased cardiomyocyte passive stiffness. Targeted therapeutic interventions effectively reduced Fpassive, with IL-6 inhibition, Mito-TEMPO, and HSP administration leading to improvements in cardiomyocyte mechanical properties.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The findings of this study elucidate a mechanistic relationship among diabetes, inflammation, oxidative stress, and PQC impairment in the context of HFpEF. Therapeutic strategies that target these dysregulated pathways, including IL-6 inhibition, mitochondrial antioxidants, and chaperone-mediated protection, may enhance myocardial function in HFpEF patients with T2DM. Addressing these molecular dysfunctions could facilitate the development of novel interventions specifically tailored to the diabetic HFpEF population.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1186\/s12933-025-02734-4","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T18:07:40Z","timestamp":1747246060000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Dysregulated inflammation, oxidative stress, and protein quality control in diabetic HFpEF: unraveling mechanisms and therapeutic targets"],"prefix":"10.1186","volume":"24","author":[{"given":"Simin","family":"Delalat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Innas","family":"Sultana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hersh","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Sieme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saltanat","family":"Zhazykbayeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Herwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Budde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1rp\u00e1d","family":"Kov\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Ka\u00e7maz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eda","family":"G\u00f6ztepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Borgmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gelareh","family":"Shahriari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Sasko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Wintrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Haldenwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang E.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"Fenske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muchtiar","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kornelia","family":"Jaquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"M\u00fcgge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domokos","family":"M\u00e1th\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikt\u00f3ria E.","family":"T\u00f3th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n V.","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Ferdinandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"El-Battrawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loek","family":"van Heerebeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazha","family":"Hamdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"issue":"10","key":"2734_CR1","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s00109-010-0663-9","volume":"88","author":"J Ren","year":"2010","unstructured":"Ren J, Pulakat L, Whaley-Connell A, Sowers JR. Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease. J Mol Med. 2010;88(10):993\u20131001. https:\/\/doi.org\/10.1007\/s00109-010-0663-9.","journal-title":"J Mol Med"},{"key":"2734_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/3106056","volume":"2018","author":"FC Sasso","year":"2018","unstructured":"Sasso FC, et al. Role of tight glycemic control during acute coronary syndrome on CV outcome in type 2 diabetes. J Diabetes Res. 2018;2018:1\u20138. https:\/\/doi.org\/10.1155\/2018\/3106056.","journal-title":"J Diabetes Res"},{"key":"2734_CR3","unstructured":"IDF Diabetes Atlas, 9th edn. Federation ID, editor. Brussels: International Diabetes Federation (2019). 2019."},{"issue":"4","key":"2734_CR4","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","volume":"122","author":"G Jia","year":"2018","unstructured":"Jia G, Hill MA, Sowers JR. Diabetic cardiomyopathy. Circ Res. 2018;122(4):624\u201338. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.311586.","journal-title":"Circ Res"},{"key":"2734_CR5","doi-asserted-by":"publisher","first-page":"154910","DOI":"10.1016\/j.metabol.2021.154910","volume":"125","author":"SS Jankauskas","year":"2021","unstructured":"Jankauskas SS, et al. Heart failure in diabetes. Metabolism. 2021;125:154910. https:\/\/doi.org\/10.1016\/j.metabol.2021.154910.","journal-title":"Metabolism"},{"issue":"4","key":"2734_CR6","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1152\/physrev.00030.2020","volume":"101","author":"J Ren","year":"2021","unstructured":"Ren J, Wu NN, Wang S, Sowers JR, Zhang Y. Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications. Physiol Rev. 2021;101(4):1745\u2013807. https:\/\/doi.org\/10.1152\/physrev.00030.2020.","journal-title":"Physiol Rev"},{"issue":"1","key":"2734_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0002-9149(74)90089-7","volume":"34","author":"WB Kannel","year":"1974","unstructured":"Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol. 1974;34(1):29\u201334. https:\/\/doi.org\/10.1016\/0002-9149(74)90089-7.","journal-title":"Am J Cardiol"},{"issue":"1","key":"2734_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/17434440.2017.1262762","volume":"14","author":"KK Marinescu","year":"2017","unstructured":"Marinescu KK, Uriel N, Mann DL, Burkhoff D. Left ventricular assist device-induced reverse remodeling: it\u2019s not just about myocardial recovery. Expert Rev Med Devices. 2017;14(1):15\u201326. https:\/\/doi.org\/10.1080\/17434440.2017.1262762.","journal-title":"Expert Rev Med Devices"},{"issue":"12","key":"2734_CR9","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1080\/17512433.2016.1242067","volume":"9","author":"WS Aronow","year":"2016","unstructured":"Aronow WS. Current treatment of heart failure with reduction of left ventricular ejection fraction. Expert Rev Clin Pharmacol. 2016;9(12):1619\u201331. https:\/\/doi.org\/10.1080\/17512433.2016.1242067.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"6","key":"2734_CR10","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1586\/14779072.2014.911086","volume":"12","author":"M Alsamara","year":"2014","unstructured":"Alsamara M, Alharethi R. Heart failure with preserved ejection fraction. Expert Rev Cardiovasc Ther. 2014;12(6):743\u201350. https:\/\/doi.org\/10.1586\/14779072.2014.911086.","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"7","key":"2734_CR11","doi-asserted-by":"publisher","first-page":"432","DOI":"10.7556\/jaoa.2015.089","volume":"115","author":"FJ Rogers","year":"2015","unstructured":"Rogers FJ, Gundala T, Ramos JE, Serajian A. Heart failure with preserved ejection fraction. J Am Osteopath Assoc. 2015;115(7):432\u201342. https:\/\/doi.org\/10.7556\/jaoa.2015.089.","journal-title":"J Am Osteopath Assoc"},{"issue":"5","key":"2734_CR12","doi-asserted-by":"publisher","first-page":"mjac028","DOI":"10.1093\/jmcb\/mjac028","volume":"14","author":"M Abudureyimu","year":"2022","unstructured":"Abudureyimu M, et al. Heart failure with preserved ejection fraction (HFpEF) in type 2 diabetes mellitus: from pathophysiology to therapeutics. J Mol Cell Biol. 2022;14(5):mjac028. https:\/\/doi.org\/10.1093\/jmcb\/mjac028.","journal-title":"J Mol Cell Biol"},{"issue":"2","key":"2734_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cmet.2015.01.016","volume":"21","author":"ZV Wang","year":"2015","unstructured":"Wang ZV, Hill JA. Protein quality control and metabolism: bidirectional control in the heart. Cell Metab. 2015;21(2):215\u201326. https:\/\/doi.org\/10.1016\/j.cmet.2015.01.016.","journal-title":"Cell Metab"},{"issue":"2","key":"2734_CR14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.bbadis.2014.05.006","volume":"1852","author":"L Yang","year":"2015","unstructured":"Yang L, Zhao D, Ren J, Yang J. Endoplasmic reticulum stress and protein quality control in diabetic cardiomyopathy. Biochim Biophys Acta (BBA) Mol Basis Dis. 2015;1852(2):209\u201318. https:\/\/doi.org\/10.1016\/j.bbadis.2014.05.006.","journal-title":"Biochim Biophys Acta (BBA) Mol Basis Dis"},{"key":"2734_CR15","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ijcard.2021.09.009","volume":"344","author":"R Hassoun","year":"2021","unstructured":"Hassoun R, et al. Stress activated signalling impaired protein quality control pathways in human hypertrophic cardiomyopathy. Int J Cardiol. 2021;344:160\u20139. https:\/\/doi.org\/10.1016\/j.ijcard.2021.09.009.","journal-title":"Int J Cardiol"},{"key":"2734_CR16","doi-asserted-by":"publisher","first-page":"585309","DOI":"10.3389\/fcvm.2020.585309","volume":"7","author":"N Kaur","year":"2020","unstructured":"Kaur N, Raja R, Ruiz-Velasco A, Liu W. Cellular protein quality control in diabetic cardiomyopathy: from bench to bedside. Front Cardiovasc Med. 2020;7:585309. https:\/\/doi.org\/10.3389\/fcvm.2020.585309.","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"2734_CR17","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1007\/s00018-004-4464-6","volume":"62","author":"MP Mayer","year":"2005","unstructured":"Mayer MP, Bukau B. Hsp70 chaperones: cellular functions and molecular mechanism. Cell Mol Life Sci. 2005;62(6):670. https:\/\/doi.org\/10.1007\/s00018-004-4464-6.","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"2734_CR18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1161\/01.RES.83.2.117","volume":"83","author":"IJ Benjamin","year":"1998","unstructured":"Benjamin IJ, McMillan DR. Stress (Heat Shock) proteins. Circ Res. 1998;83(2):117\u201332. https:\/\/doi.org\/10.1161\/01.RES.83.2.117.","journal-title":"Circ Res"},{"issue":"4","key":"2734_CR19","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.addr.2009.02.003","volume":"61","author":"B Kalmar","year":"2009","unstructured":"Kalmar B, Greensmith L. Induction of heat shock proteins for protection against oxidative stress. Adv Drug Deliv Rev. 2009;61(4):310\u20138. https:\/\/doi.org\/10.1016\/j.addr.2009.02.003.","journal-title":"Adv Drug Deliv Rev"},{"key":"2734_CR20","doi-asserted-by":"publisher","unstructured":"Arrigo, A-P. The cellular \u2018networking\u2019 of mammalian Hsp27 and its functions in the control of protein folding, redox state and apoptosis. In Molecular aspects of the stress response: chaperones, membranes and networks, New York: Springer New York; pp. 14\u201326. https:\/\/doi.org\/10.1007\/978-0-387-39975-1_2.","DOI":"10.1007\/978-0-387-39975-1_2"},{"issue":"7","key":"2734_CR21","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.febslet.2010.01.009","volume":"584","author":"RC Wang","year":"2010","unstructured":"Wang RC, Levine B. Autophagy in cellular growth control. FEBS Lett. 2010;584(7):1417\u201326. https:\/\/doi.org\/10.1016\/j.febslet.2010.01.009.","journal-title":"FEBS Lett"},{"issue":"3","key":"2734_CR22","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1556\/APhysiol.96.2009.3.2","volume":"96","author":"N Gurusamy","year":"2009","unstructured":"Gurusamy N, Das D. Is autophagy a double-edged sword for the heart? Acta Physiol Hung. 2009;96(3):267\u201376. https:\/\/doi.org\/10.1556\/APhysiol.96.2009.3.2.","journal-title":"Acta Physiol Hung"},{"issue":"6","key":"2734_CR23","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.cell.2010.02.034","volume":"140","author":"GS Hotamisligil","year":"2010","unstructured":"Hotamisligil GS. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell. 2010;140(6):900\u201317. https:\/\/doi.org\/10.1016\/j.cell.2010.02.034.","journal-title":"Cell"},{"key":"2734_CR24","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.mce.2016.04.006","volume":"430","author":"YK Chan","year":"2016","unstructured":"Chan YK, Sung HK, Jahng JWS, Kim GHE, Han M, Sweeney G. Lipocalin-2 inhibits autophagy and induces insulin resistance in H9c2 cells. Mol Cell Endocrinol. 2016;430:68\u201376. https:\/\/doi.org\/10.1016\/j.mce.2016.04.006.","journal-title":"Mol Cell Endocrinol"},{"issue":"7","key":"2734_CR25","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.febslet.2010.01.017","volume":"584","author":"CH Jung","year":"2010","unstructured":"Jung CH, Ro S-H, Cao J, Otto NM, Kim D-H. mTOR regulation of autophagy. FEBS Lett. 2010;584(7):1287\u201395. https:\/\/doi.org\/10.1016\/j.febslet.2010.01.017.","journal-title":"FEBS Lett"},{"key":"2734_CR26","doi-asserted-by":"publisher","first-page":"1015500","DOI":"10.3389\/fphys.2022.1015500","volume":"13","author":"S Wang","year":"2022","unstructured":"Wang S, Li H, Yuan M, Fan H, Cai Z. Role of AMPK in autophagy. Front Physiol. 2022;13:1015500. https:\/\/doi.org\/10.3389\/fphys.2022.1015500.","journal-title":"Front Physiol"},{"key":"2734_CR27","doi-asserted-by":"publisher","first-page":"173376","DOI":"10.1016\/j.ejphar.2020.173376","volume":"888","author":"A Haye","year":"2020","unstructured":"Haye A, Ansari MA, Rahman SO, Shamsi Y, Ahmed D, Sharma M. Role of AMP-activated protein kinase on cardio-metabolic abnormalities in the development of diabetic cardiomyopathy: a molecular landscape. Eur J Pharmacol. 2020;888:173376. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173376.","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"2734_CR28","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1161\/CIRCRESAHA.114.302022","volume":"114","author":"S Sciarretta","year":"2014","unstructured":"Sciarretta S, Volpe M, Sadoshima J. Mammalian target of rapamycin signaling in cardiac physiology and disease. Circ Res. 2014;114(3):549\u201364. https:\/\/doi.org\/10.1161\/CIRCRESAHA.114.302022.","journal-title":"Circ Res"},{"issue":"8","key":"2734_CR29","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.bbadis.2013.03.013","volume":"1832","author":"R Guo","year":"2013","unstructured":"Guo R, Zhang Y, Turdi S, Ren J. Adiponectin knockout accentuates high fat diet-induced obesity and cardiac dysfunction: role of autophagy. Biochim Biophys Acta (BBA) Mol Basis Dis. 2013;1832(8):1136\u201348. https:\/\/doi.org\/10.1016\/j.bbadis.2013.03.013.","journal-title":"Biochim Biophys Acta (BBA) Mol Basis Dis"},{"issue":"8","key":"2734_CR30","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1016\/j.bbadis.2017.01.010","volume":"1863","author":"N Hu","year":"2017","unstructured":"Hu N, Zhang Y. TLR4 knockout attenuated high fat diet-induced cardiac dysfunction via NF-\u03baB\/JNK-dependent activation of autophagy. Biochim Biophys Acta (BBA) Mol Basis Dis. 2017;1863(8):2001\u201311. https:\/\/doi.org\/10.1016\/j.bbadis.2017.01.010.","journal-title":"Biochim Biophys Acta (BBA) Mol Basis Dis"},{"issue":"2","key":"2734_CR31","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.bbadis.2014.07.004","volume":"1852","author":"MR Kandadi","year":"2015","unstructured":"Kandadi MR, Panzhinskiy E, Roe ND, Nair S, Hu D, Sun A. Deletion of protein tyrosine phosphatase 1B rescues against myocardial anomalies in high fat diet-induced obesity: role of AMPK-dependent autophagy. Biochim Biophys Acta (BBA) Mol Basis Dis. 2015;1852(2):299\u2013309. https:\/\/doi.org\/10.1016\/j.bbadis.2014.07.004.","journal-title":"Biochim Biophys Acta (BBA) Mol Basis Dis"},{"key":"2734_CR32","doi-asserted-by":"publisher","first-page":"1125687","DOI":"10.3389\/fcvm.2023.1125687","volume":"10","author":"ZH Peh","year":"2023","unstructured":"Peh ZH, et al. Inflammation as a therapeutic target in heart failure with preserved ejection fraction. Front Cardiovasc Med. 2023;10:1125687. https:\/\/doi.org\/10.3389\/fcvm.2023.1125687.","journal-title":"Front Cardiovasc Med"},{"issue":"10","key":"2734_CR33","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.4161\/cc.4.10.2047","volume":"4","author":"B Graham","year":"2005","unstructured":"Graham B, Gibson SB. The two faces of NF?B in cell survival responses. Cell Cycle. 2005;4(10):1342\u20135. https:\/\/doi.org\/10.4161\/cc.4.10.2047.","journal-title":"Cell Cycle"},{"issue":"3","key":"2734_CR34","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1093\/cvr\/cvs353","volume":"97","author":"N Hamdani","year":"2013","unstructured":"Hamdani N, Bishu KG, von Frieling-Salewsky M, Redfield MM, Linke WA. Deranged myofilament phosphorylation and function in experimental heart failure with preserved ejection fraction. Cardiovasc Res. 2013;97(3):464\u201371. https:\/\/doi.org\/10.1093\/cvr\/cvs353.","journal-title":"Cardiovasc Res"},{"issue":"2","key":"2734_CR35","doi-asserted-by":"publisher","first-page":"18a","DOI":"10.1016\/j.bpj.2012.11.129","volume":"104","author":"N Hamdani","year":"2013","unstructured":"Hamdani N, et al. Crucial role for Ca2+\/calmodulin-dependent protein kinase-II delta in regulating diastolic stress of normal and failing hearts via titin phosphorylation. Biophys J. 2013;104(2):18a. https:\/\/doi.org\/10.1016\/j.bpj.2012.11.129.","journal-title":"Biophys J"},{"issue":"2","key":"2734_CR36","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/cvr\/cvaa123","volume":"117","author":"D Kolijn","year":"2021","unstructured":"Kolijn D, et al. Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase G\u03b1 oxidation. Cardiovasc Res. 2021;117(2):495\u2013507. https:\/\/doi.org\/10.1093\/cvr\/cvaa123.","journal-title":"Cardiovasc Res"},{"issue":"5","key":"2734_CR37","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.3390\/ijms25052790","volume":"25","author":"M Herwig","year":"2024","unstructured":"Herwig M, et al. Protein kinase D plays a crucial role in maintaining cardiac homeostasis by regulating post-translational modifications of myofilament proteins. Int J Mol Sci. 2024;25(5):2790. https:\/\/doi.org\/10.3390\/ijms25052790.","journal-title":"Int J Mol Sci"},{"key":"2734_CR38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fphys.2020.00345","volume":"11","author":"D Kolijn","year":"2020","unstructured":"Kolijn D, et al. Enhanced cardiomyocyte function in hypertensive rats with diastolic dysfunction and human heart failure patients after acute treatment with soluble guanylyl cyclase (sGC) activator. Front Physiol. 2020;11:35. https:\/\/doi.org\/10.3389\/fphys.2020.00345.","journal-title":"Front Physiol"},{"issue":"4","key":"2734_CR39","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jchf.2015.10.007","volume":"4","author":"C Franssen","year":"2016","unstructured":"Franssen C, et al. Myocardial microvascular inflammatory endothelial activation in heart failure with preserved ejection fraction. JACC Heart Fail. 2016;4(4):312\u201324. https:\/\/doi.org\/10.1016\/j.jchf.2015.10.007.","journal-title":"JACC Heart Fail"},{"issue":"7","key":"2734_CR40","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1161\/CIRCULATIONAHA.111.076075","volume":"126","author":"L van Heerebeek","year":"2012","unstructured":"van Heerebeek L, et al. Low myocardial protein kinase G activity in heart failure with preserved ejection fraction. Circulation. 2012;126(7):830\u20139. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.076075.","journal-title":"Circulation"},{"issue":"5","key":"2734_CR41","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1007\/s10787-024-01556-2","volume":"32","author":"A Satheesan","year":"2024","unstructured":"Satheesan A, Kumar J, Leela KV, Murugesan R, Chaithanya V, Angelin M. Review on the role of nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome pathway in diabetes: mechanistic insights and therapeutic implications. Inflammopharmacology. 2024;32(5):2753\u201379. https:\/\/doi.org\/10.1007\/s10787-024-01556-2.","journal-title":"Inflammopharmacology"},{"issue":"1","key":"2734_CR42","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun S-C. NF-\u03baB signaling in inflammation. Signal Transduct Target Ther. 2017;2(1):17023. https:\/\/doi.org\/10.1038\/sigtrans.2017.23.","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"2734_CR43","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.jacc.2010.10.024","volume":"57","author":"M Kasner","year":"2011","unstructured":"Kasner M, et al. Diastolic tissue Doppler indexes correlate with the degree of collagen expression and cross-linking in heart failure and normal ejection fraction. J Am Coll Cardiol. 2011;57(8):977\u201385. https:\/\/doi.org\/10.1016\/j.jacc.2010.10.024.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"2734_CR44","doi-asserted-by":"publisher","first-page":"e13453","DOI":"10.1111\/acel.13453","volume":"20","author":"T Mesquita","year":"2021","unstructured":"Mesquita T, Lin Y, Ibrahim A. Chronic low-grade inflammation in heart failure with preserved ejection fraction. Aging Cell. 2021;20(9):e13453. https:\/\/doi.org\/10.1111\/acel.13453.","journal-title":"Aging Cell"},{"issue":"1","key":"2734_CR45","doi-asserted-by":"publisher","first-page":"E130","DOI":"10.1152\/ajpendo.00158.2021","volume":"321","author":"ED Abel","year":"2021","unstructured":"Abel ED. Insulin signaling in the heart. Am J Physiol Endocrinol Metab. 2021;321(1):E130\u201345. https:\/\/doi.org\/10.1152\/ajpendo.00158.2021.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"2734_CR46","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cmet.2004.12.003","volume":"1","author":"BB Kahn","year":"2005","unstructured":"Kahn BB, Alquier T, Carling D, Hardie DG. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 2005;1(1):15\u201325. https:\/\/doi.org\/10.1016\/j.cmet.2004.12.003.","journal-title":"Cell Metab"},{"issue":"10","key":"2734_CR47","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/nrm2249","volume":"8","author":"DG Hardie","year":"2007","unstructured":"Hardie DG. AMP-activated\/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol. 2007;8(10):774\u201385. https:\/\/doi.org\/10.1038\/nrm2249.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"2734_CR48","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s11892-017-0865-4","volume":"17","author":"T Suhara","year":"2017","unstructured":"Suhara T, Baba Y, Shimada BK, Higa JK, Matsui T. The mTOR signaling pathway in myocardial dysfunction in type 2 diabetes mellitus. Curr Diabets Rep. 2017;17(6):38. https:\/\/doi.org\/10.1007\/s11892-017-0865-4.","journal-title":"Curr Diabets Rep"},{"issue":"11","key":"2734_CR49","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/nrm2043","volume":"7","author":"P Cohen","year":"2006","unstructured":"Cohen P. The twentieth century struggle to decipher insulin signalling. Nat Rev Mol Cell Biol. 2006;7(11):867\u201373. https:\/\/doi.org\/10.1038\/nrm2043.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"S1","key":"2734_CR50","doi-asserted-by":"publisher","first-page":"S137","DOI":"10.1038\/sj.bjp.0707659","volume":"153","author":"PH Sugden","year":"2008","unstructured":"Sugden PH, Fuller SJ, Weiss SC, Clerk A. Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis. Br J Pharmacol. 2008;153(S1):S137\u201353. https:\/\/doi.org\/10.1038\/sj.bjp.0707659.","journal-title":"Br J Pharmacol"},{"issue":"4","key":"2734_CR51","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1093\/cvr\/cvx011","volume":"113","author":"G Frati","year":"2017","unstructured":"Frati G, et al. An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy. Cardiovasc Res. 2017;113(4):378\u201388. https:\/\/doi.org\/10.1093\/cvr\/cvx011.","journal-title":"Cardiovasc Res"},{"issue":"8","key":"2734_CR52","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/ni.2065","volume":"12","author":"A Oeckinghaus","year":"2011","unstructured":"Oeckinghaus A, Hayden MS, Ghosh S. Crosstalk in NF-\u03baB signaling pathways. Nat Immunol. 2011;12(8):695\u2013708. https:\/\/doi.org\/10.1038\/ni.2065.","journal-title":"Nat Immunol"},{"issue":"3","key":"2734_CR53","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/cvr\/cvp305","volume":"85","author":"N Mariappan","year":"2010","unstructured":"Mariappan N, et al. NF-\u03baB-induced oxidative stress contributes to mitochondrial and cardiac dysfunction in type II diabetes. Cardiovasc Res. 2010;85(3):473\u201383. https:\/\/doi.org\/10.1093\/cvr\/cvp305.","journal-title":"Cardiovasc Res"},{"issue":"7","key":"2734_CR54","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.2337\/diabetes.51.7.2241","volume":"51","author":"G Romeo","year":"2002","unstructured":"Romeo G, Liu W-H, Asnaghi V, Kern TS, Lorenzi M. Activation of nuclear factor-\u03baB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes. 2002;51(7):2241\u20138. https:\/\/doi.org\/10.2337\/diabetes.51.7.2241.","journal-title":"Diabetes"},{"issue":"10","key":"2734_CR55","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.2337\/db13-1577","volume":"63","author":"Y Pan","year":"2014","unstructured":"Pan Y, et al. Inhibition of JNK phosphorylation by a novel curcumin analog prevents high glucose-induced inflammation and apoptosis in cardiomyocytes and the development of diabetic cardiomyopathy. Diabetes. 2014;63(10):3497\u2013511. https:\/\/doi.org\/10.2337\/db13-1577.","journal-title":"Diabetes"},{"issue":"7","key":"2734_CR56","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/nm.3887","volume":"21","author":"SL Wong","year":"2015","unstructured":"Wong SL, et al. Diabetes primes neutrophils to undergo NETosis, which impairs wound healing. Nat Med. 2015;21(7):815\u20139. https:\/\/doi.org\/10.1038\/nm.3887.","journal-title":"Nat Med"},{"issue":"3","key":"2734_CR57","doi-asserted-by":"publisher","first-page":"R131","DOI":"10.1530\/JOE-16-0679","volume":"233","author":"CA Guo","year":"2017","unstructured":"Guo CA, Guo S. Insulin receptor substrate signaling controls cardiac energy metabolism and heart failure. J Endocrinol. 2017;233(3):R131\u201343. https:\/\/doi.org\/10.1530\/JOE-16-0679.","journal-title":"J Endocrinol"},{"issue":"19","key":"2734_CR58","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2016;375(19):1834\u201344. https:\/\/doi.org\/10.1056\/NEJMoa1607141.","journal-title":"N Engl J Med"},{"key":"2734_CR59","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.freeradbiomed.2015.11.013","volume":"90","author":"R Ni","year":"2016","unstructured":"Ni R, et al. Therapeutic inhibition of mitochondrial reactive oxygen species with mito-TEMPO reduces diabetic cardiomyopathy. Free Radic Biol Med. 2016;90:12\u201323. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2015.11.013.","journal-title":"Free Radic Biol Med"},{"issue":"8","key":"2734_CR60","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.tem.2015.05.010","volume":"26","author":"D Qi","year":"2015","unstructured":"Qi D, Young LH. AMPK: energy sensor and survival mechanism in the ischemic heart. Trends Endocrinol Metab. 2015;26(8):422\u20139. https:\/\/doi.org\/10.1016\/j.tem.2015.05.010.","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"2734_CR61","doi-asserted-by":"publisher","first-page":"696","DOI":"10.2337\/db07-1098","volume":"57","author":"JW Calvert","year":"2008","unstructured":"Calvert JW, et al. Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS\u2013mediated signaling. Diabetes. 2008;57(3):696\u2013705. https:\/\/doi.org\/10.2337\/db07-1098.","journal-title":"Diabetes"},{"issue":"2","key":"2734_CR62","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149(2):274\u201393. https:\/\/doi.org\/10.1016\/j.cell.2012.03.017.","journal-title":"Cell"},{"issue":"1","key":"2734_CR63","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1172\/JCI73939","volume":"125","author":"YC Kim","year":"2015","unstructured":"Kim YC, Guan K-L. mTOR: a pharmacologic target for autophagy regulation. J Clin Investig. 2015;125(1):25\u201332. https:\/\/doi.org\/10.1172\/JCI73939.","journal-title":"J Clin Investig"},{"issue":"3","key":"2734_CR64","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/ncb1547","volume":"9","author":"E VanderHaar","year":"2007","unstructured":"VanderHaar E, Lee S, Bandhakavi S, Griffin TJ, Kim D-H. Insulin signalling to mTOR mediated by the Akt\/PKB substrate PRAS40. Nat Cell Biol. 2007;9(3):316\u201323. https:\/\/doi.org\/10.1038\/ncb1547.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"2734_CR65","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.yjmcc.2008.03.025","volume":"45","author":"X Wang","year":"2008","unstructured":"Wang X, Su H, Ranek MJ. Protein quality control and degradation in cardiomyocytes. J Mol Cell Cardiol. 2008;45(1):11\u201327. https:\/\/doi.org\/10.1016\/j.yjmcc.2008.03.025.","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"2734_CR66","doi-asserted-by":"publisher","first-page":"H249","DOI":"10.1152\/ajpheart.00775.2007","volume":"294","author":"CL Williamson","year":"2008","unstructured":"Williamson CL, Dabkowski ER, Dillmann WH, Hollander JM. Mitochondria protection from hypoxia\/reoxygenation injury with mitochondria heat shock protein 70 overexpression. Am J Physiol Heart Circ Physiol. 2008;294(1):H249\u201356. https:\/\/doi.org\/10.1152\/ajpheart.00775.2007.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2734_CR67","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.yjmcc.2018.04.016","volume":"119","author":"DL Shepherd","year":"2018","unstructured":"Shepherd DL, et al. Mitochondrial proteome disruption in the diabetic heart through targeted epigenetic regulation at the mitochondrial heat shock protein 70 (mtHsp70) nuclear locus. J Mol Cell Cardiol. 2018;119:104\u201315. https:\/\/doi.org\/10.1016\/j.yjmcc.2018.04.016.","journal-title":"J Mol Cell Cardiol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02734-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02734-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02734-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T18:07:45Z","timestamp":1747246065000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02734-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2734"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02734-4","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"assertion":[{"value":"19 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All samples were obtained with informed consent and approval from the local Ethics Committee. All procedures were performed according to the Declaration of Helsinki and were approved by the local ethics committee. Biopsies were obtained for the primary purpose of diagnosis following Ethics Committee approval numbers WO18.026, 20-6976 BR, 20-6976-1- BR and informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"211"}}